Mind Cure Health (CSE: MCUR) has received the required authorizations from Health Canada for its functional mushroom products to begin to be sold within the country. The company has seen its branded Moonbeam Mushrooms products issued Natural Product Numbers the agency, enabling for the sale of the products at retailers.
The authorizations put the product line ahead of many competitors within the supplement and nutrition space whom often skip the task of receiving Health Canada compliance. Having the approval from the agency will provide additional transparency to consumers, while providing evidence that the products are in fact considered natural supplements.
The Moonbeam Mushrooms product line consists of three offerings, each of which is offered in the form of powder and capsules. The products are focused on different functional mushrooms, including Lion’s Mane, Reishi, and Turkey Tail. Further, they have been marked as being non-GMO, vegan, organic, free of soy as well as gluten. New product offerings from the firm are currently being investigated as well, in the fields of nootropics, psychoactive products and psychedelic substances.
A timeline for products to hit retailers was not provided.
Mind Cure Health last traded at $0.55 on the CSE.
FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.